Health in Fiji 1,009 indicators covering health for Fiji. IndicatorLatest Year10-yr change Rank Export of environmentally sound technologies 114.61 million 2020 up 62.0% 87th Pcv3 number unvaccinated 655.24 2023 down 73.7% 128th Proportion of births delivered in a health facility (Facility births) 99.7% 2021 up 0.7% 20th Number of non-autochthonous leprosy cases 2 2024 up 100.0% 29th Maternal mortality ratio 59.5 2012 up 68.6% 23rd Population with basic handwashing facilities at home 80.1% 2024 unchanged 43rd HPV immunization coverage estimates among primary target cohort (9-14) 88.0% 2025 up 10.0% 26th How many health warnings are approved by the law for cigarette 5 2022 unchanged 97th Tuberculosis - new and relapse cases 208 2011 up 13.7% 157th Coverage of the human papillomavirus vaccine 53 2024 down 3.6% 51st Percentage of principal display area mandated to be covered by health 60 2022 unchanged 69th New cases: pulmonary smear-negative 54 2012 up 58.8% 150th Estimated number of pregnant women living with HIV needing 200 2024 up 100.0% 70th Percentage of principal display area mandated to be covered by health 30 2022 unchanged 117th Percentage of principal display area mandated to be covered by health 90 2022 unchanged 7th Average death rate due to natural disasters 76.9 2021 up 69,749.5% 17th Number of full-time equivalent staff in national agency 5 2022 down 61.5% 50th Total number of notified TB cases 385 2014 up 187.3% 142nd The number of people with susceptibility test result for rifampicin 127 2021 — 105th Estimated number of pregnant women living with HIV 68 2024 up 47.8% 58th New cases: pulmonary smear unknown/not done 0 2012 — 109th Smear-positive tuberculosis treatment-success rate 93.0% 2011 up 9.4% 13th Share of one year olds who received the rotavirus vaccine 94 2024 down 5.1% 15th How many health warnings are approved by the law for other smoked 5 2022 unchanged 88th Insufficiently active 83.28 2016 down 0.7% 78th Percentage of principal display area mandated to be covered by health 33 2022 down 45.0% 110th The number of people with susceptibility test result for rifampicin 96.21 2021 — 45th Percentage of principal display area mandated to be covered by health 35 2022 down 61.1% 108th Percentage of principal display area mandated to be covered by health 30 2022 unchanged 105th Retreatment cases: treatment after default 5 2012 — 109th Retreatment cases: other 2 2012 — 111th Retreatment cases: treatment after failure 1 2012 — 114th Absolute number of deaths from ambient particulate air pollution 200 2015 unchanged 158th Tuberculosis funding versus budget requirement 177,158 2025 down 46.7% 83rd Laboratories providing tuberculosis diagnostic services using culture 5.6 2014 down 8.2% 63rd Laboratories providing tuberculosis diagnostic services using sputum 0.6 2014 unchanged 108th Average cost of tuberculosis treatment multi drug resistant 700 2022 down 88.3% 68th Number of people who received treatment with antibiotics for trachoma 0 2025 — 22nd Hpv vaccination coverage in 15 year olds 64 2024 down 29.7% 50th Population in areas that warrant treatment with antibiotics, facial 0 2025 down 100.0% 23rd Sales of beer in 1000s hectolitres 162 2009 down 12.9% 48th Confirmed cases of MDR-TB 0 2012 — 125th Number of people operated for trachomatous trichiasis 0 2025 — 41st New cases: other 0 2012 — 33rd HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) 100.0% 2014 up 49.3% 1st Commitments to recipient countries 11.65 2010 up 404.3% 98th Disbursements to recipient countries 9.31 2010 up 13.3% 102nd Proportion of isolates with resistance to ciprofloxacin reported to 1.96 2018 up 960.8% 53rd Number of isolates tested for ciprofloxacin 51 2018 down 90.6% 39th ← Previous Page 17 of 17